ACTRN12612000796886尚未招募不适用
For healthy human volunteers, what is the dose-dependent independent and combined impact of alcohol and energy drinks on cognitive and motor performance, physiology, and behavioural risk-taking outcomes
School of Psychology, University of Tasmania0 个研究点目标入组 46 人开始时间: 2012年7月30日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 46
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Educational / counselling / training
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 35 Years(—)
- 性别
- All
入选标准
- •Male or female
- •Aged 18 to 35
- •English as a first language
- •Completed Year 12 or equivalent
- •Current full driver licence
- •Regular energy drink consumer (minimum consumption of one energy drink and maximum consumption of one energy drink per day on average in the preceding month)
- •Regular caffeine consumer (minimum consumption of five and maximum consumption of 28 caffeinated products in the preceding week)
- •Regular alcohol consumer (minimum consumption of two standard alcoholic beverages in the preceding fortnight)
- •Normal or corrected-to-normal vision
- •Normal sleep patterns
- •Normal Body Mass Index (BMI; between 18.50 and 29.99)
- •Provided informed consent
排除标准
- •Regular tobacco smoker (typical daily use of one or more cigarettes)
- •Recent illicit drug use (preceding two weeks)
- •Current regular medicinal or recreational prescription medication use (excluding the contraceptive pill)
- •Participation in a drug study in the preceding three months
- •Currently pregnant or breastfeeding
- •History of any significant neurological condition
- •Current diagnosis of any significant physical condition
- •Current diagnosis of a significant psychiatric disorder or score of 30 or higher on the Kessler Psychological Distress Scale (K10; Kessler et al., 2002)
- •Current diagnosis of a significant intellectual disability or age normed quotient lower than 71 on the Wechsler Test of Adult Reading (WTAR; Wechsler, 2001)
- •History of alcohol or drug abuse or dependence disorder or use of alcohol at hazardous or harmful levels, evident via a score of 16 or higher on the Alcohol Use Disorders Identification Test (AUDIT; Barbor et al., 2001; Saunders, Aasland, Babor, de la Fuente, & Grant, 1993)
研究者
相似试验
进行中(未招募)
不适用
Determination of the efficacious and safe dose of ivabradine in paediatric patients with dilated cardiomyopathy and symptomatic chronic heart failure aged from 6 months to less than 18 yearsEUCTR2011-001292-39-DEInstitut de Recherches Internationales Servier90
进行中(未招募)
不适用
Determination of the efficacious and safe dose of ivabradine in paediatric patients with dilated cardiomyopathy and symptomatic chronic heart failure aged from 6 months to less than 18 yearsEUCTR2011-001292-39-HUInstitut de Recherches Internationales Servier90
进行中(未招募)
不适用
Determination of the efficacious and safe dose of ivabradine in paediatric patients with dilated cardiomyopathy and symptomatic chronic heart failure aged from 6 months to less than 18 yearsPaediatric dilated cardiomyopathy and symptomatic chronic heart failureMedDRA version: 14.1Level: LLTClassification code 10008908Term: Chronic heart failureSystem Organ Class: 10007541 - Cardiac disordersEUCTR2011-001292-39-SEInstitut de Recherches Internationales Servier90
进行中(未招募)
1 期
Determination of the efficacious and safe dose of ivabradine in paediatric patients with dilated cardiomyopathy and symptomatic chronic heart failure aged from 6 months to less than 18 yearsPaediatric dilated cardiomyopathy and symptomatic chronic heart failureMedDRA version: 14.1Level: LLTClassification code 10008908Term: Chronic heart failureSystem Organ Class: 10007541 - Cardiac disordersEUCTR2011-001292-39-ESab Servier116
进行中(未招募)
1 期
Determination of the efficacious and safe dose of ivabradine in paediatric patients with dilated cardiomyopathy and symptomatic chronic heart failure aged from 6 months to less than 18 years.Paediatric dilated cardiomyopathy and symptomatic chronic heart failureMedDRA version: 16.0 Level: LLT Classification code 10008908 Term: Chronic heart failure System Organ Class: 100000004849EUCTR2011-001292-39-GBInstitut de Recherches Internationales Servier116
